On the development of the European S3 guidelines on the systemic treatment of psoriasis vulgaris: structure and challenges

2010 ◽  
Vol 24 (12) ◽  
pp. 1458-1467 ◽  
Author(s):  
D Pathirana ◽  
A Nast ◽  
AD Ormerod ◽  
N Reytan ◽  
P Saiag ◽  
...  
Keyword(s):  
Psoriasis Vulgaris ◽  
Systemic Treatment ◽  
S3 Guidelines

scholarly journals European S3-Guidelines on the systemic treatment of psoriasis vulgaris

2009 ◽  
Vol 23 ◽  
pp. 1-70 ◽  
Author(s):  
D Pathirana ◽  
AD Ormerod ◽  
P Saiag ◽  
C Smith ◽  
PI Spuls ◽  
...  
Keyword(s):  
Psoriasis Vulgaris ◽  
Systemic Treatment ◽  
S3 Guidelines

scholarly journals EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations

2020 ◽  
Vol 34 (11) ◽  
pp. 2461-2498
Author(s):  
A. Nast ◽  
C. Smith ◽  
P.I. Spuls ◽  
G. Avila Valle ◽  
Z. Bata‐Csörgö ◽  
...  
Keyword(s):  
Psoriasis Vulgaris ◽  
Systemic Treatment

scholarly journals EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations

2021 ◽  
Vol 35 (2) ◽  
pp. 281-317
Author(s):  
A. Nast ◽  
C. Smith ◽  
P.I. Spuls ◽  
G. Avila Valle ◽  
Z. Bata‐Csörgö ◽  
...  
Keyword(s):  
Psoriasis Vulgaris ◽  
Systemic Treatment

HLA-G 14-bp polymorphism: a possible marker of systemic treatment response in psoriasis vulgaris? Preliminary results of a retrospective study

2014 ◽  
Vol 27 (5) ◽  
pp. 284-289 ◽  
Author(s):  
Alessandro Borghi ◽  
Roberta Rizzo ◽  
Monica Corazza ◽  
Alberto Maria Bertoldi ◽  
Daria Bortolotti ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Treatment Response ◽  
Psoriasis Vulgaris ◽  
Systemic Treatment ◽  
Preliminary Results ◽  
G 14

Topical treatment of chronic dermatoses with kertoplastic agents

2016 ◽  
Vol 19 (3) ◽  
pp. 170-172
Author(s):  
O. V Grabovskaya ◽  
E. Yu Vertieva ◽  
L. A Shestakova ◽  
Ekaterina V. Grekova
Keyword(s):  
Atopic Dermatitis ◽  
Topical Treatment ◽  
Psoriasis Vulgaris ◽  
Skin Diseases ◽  
Systemic Treatment ◽  
Skin Condition ◽  
Results Of Treatment ◽  
Severity Of The Disease

Atopic dermatitis and psoriasis are common chronic dermatosis characterized by prolonged recurrent course. Depending on the severity of the disease topical and systemic treatment are applied. Keratoplastic agents play an important role in treatment of skin diseases. These agents include Naftalan Cream 30%, which significantly improves the skin condition. The results of treatment of 10 patients with atopic dermatitis and 10 patients with psoriasis vulgaris Naftalan cream 30% are presented.

Evidence-based (S3) guidelines for the treatment of psoriasis vulgaris

2007 ◽  
Vol 5 (s3) ◽  
pp. 1-119 ◽  
Author(s):  
Alexander Nast ◽  
Ina B. Kopp ◽  
Matthias Augustin ◽  
Kirstin-Benita Banditt ◽  
Wolf-Henning Boehncke ◽  
...  
Keyword(s):  
Psoriasis Vulgaris ◽  
Evidence Based ◽  
S3 Guidelines

Systemic treatment with corticosteroids in psoriasis-health care provision far beyond the S3-guidelines

2011 ◽  
Vol 9 (10) ◽  
pp. 833-838 ◽  
Author(s):  
Matthias Augustin ◽  
Ines Schäfer ◽  
Kristian Reich ◽  
Gerd Glaeske ◽  
Marc Radtke
Keyword(s):  
Health Care ◽  
Systemic Treatment ◽  
Health Care Provision ◽  
Care Provision ◽  
S3 Guidelines
Sign in / Sign up

Export Citation Format

Share Document